Relapse Risk in Patients with Membranous Nephropathy after Inactivated COVID-19 Vaccination
Getting the inactivated COVID-19 vaccine may not increase risk of relapse or worsening in patients with membranous nephropathy.
Authors
- Qionghong Xie (ORCID: https://orcid.org/0000-0002-6189-2909)
- Jie Zhou (ORCID: https://orcid.org/0000-0002-2948-3873)
- Min Zhang (ORCID: https://orcid.org/0000-0003-3568-7351)
- Wenqian Zhao (ORCID: https://orcid.org/0000-0001-9501-9254)
- Xiaoyun Huang (ORCID: https://orcid.org/0000-0002-3389-9759)
- Hanzhen Zhang (ORCID: https://orcid.org/0000-0002-1113-4827)
- 大蔵 村上
- Chuan‐Ming Hao (ORCID: https://orcid.org/0000-0002-4307-0987)
- Yunyu Xu (ORCID: https://orcid.org/0000-0002-1452-3211)
- Mingyue Xu (ORCID: https://orcid.org/0009-0003-7793-344X)
- Ruiying Chen (ORCID: https://orcid.org/0000-0003-2556-7604)
Institutions
- Fudan University (CN)
- Huashan Hospital (CN)
Publication Details
- Journal
- The Nephron journals/Nephron journals
- Published
- 2025-04-02
- DOI
- https://doi.org/10.1159/000544754
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 0.00